Physician profile
Morgan Moon
NPI 1376063305
$17,594.40
in general payments reported to CMS, 2019-2025
16 companies · $3,644 in 2025
The $3,644 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $672 · 2021: $1,714 · 2022: $3,382 · 2023: $4,522 · 2024: $2,925 · 2025: $3,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,791 · Food and Beverage: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,791.16 |
| Food and Beverage | $3,299.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,704.64 | 2022-2025 | |
| Wardlow Enterprises | $3,445.72 | 2022-2023 | |
| Prism Medical | $2,776.52 | 2024-2025 | |
| Stryker Corporation | $2,650.37 | 2019-2024 | Aequalis Perform, Aequalis Flex Revive, Blueprint Patient Specific Instrumentation |
| Elite Orthopedics, LLC | $1,215.82 | 2021 | |
| Medical Device Business Services, INC. | $799.97 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $353.15 | 2019-2022 | |
| Radius Health, INC. | $221.68 | 2019-2025 | Tymlos |
| Nalu Medical, INC. | $101.38 | 2025 | Nalu Neurostimulation System |
| Kci USA, INC. | $100.34 | 2019 | |
| Depuy Synthes Sales INC. | $70.16 | 2020-2023 | Monovisc, Peak, Orthovisc |
| Amgen INC. | $50.72 | 2023-2024 | Evenity, Prolia |
| Ferring Pharmaceuticals INC. | $42.63 | 2025 | Euflexxa |
| Merck Sharp & Dohme LLC | $22.49 | 2025 | Bridion |
| Orthofix Medical, INC. | $20.60 | 2023 | Physio-Stim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $18.21 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.